Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC-Reference-Cited by-同舟云学术

Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC

Published:2019-04-13 Issue:8 Volume:8 Page:1602460
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Martínez Roberto¹,Tapia Gustavo²,De Muga Silvia³,Hernández Alba²,Cao Maria González⁴,Teixidó Cristina⁵⁶,Urrea Victor³,García Elisabet³,Pedreño-López Sònia³,Ibarz Luis¹,Blanco Julià³⁷,Clotet Bonaventura³⁷,Cabrera Cecilia³

Affiliation:

1. Urology Department, Hospital Universitario Germans Trias i Pujol, IGTP, UAB, Badalona, Spain

2. Pathology Department, Hospital Universitario Germans Trias i Pujol, IGTP, UAB, Badalona, Spain

3. IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP) UAB, Badalona, Spain

4. Dr. Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain

5. Pangaea Biotech, Quirón Dexeus University Hospital, Barcelona, Spain

6. Pathology Department, Hospital Clinic de Barcelona, Barcelona, Spain

7. AIDS and Related Illnesses, Centre for Health and Social Care Research (CESS), Faculty of Medicine, University of Vic – Central University of Catalonia (UVic – UCC), Vic, Barcelona, Spain

Funder

IrsiCaixa

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1602460

Reference42 articles.

1. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

2. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

3. Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review